Since the first two complete bacterial genome sequences were published in 1995, the
science of bacteria has dramatically changed. Using third-generation DNA sequencing, it is …

Systematic characterization of the cancer microbiome provides a unique opportunity to
develop cancer diagnostics that exploit non-human, microbial-derived molecules in a major …

Rapid growth of genome data provides opportunities for updating microbial evolutionary
relationships, but this is challenged by the discordant evolution of individual genes. Here we …

Mycobacterium tuberculosis and Mycobacterium leprae have remained, for many years, the
primary species of the genus Mycobacterium of clinical and microbiological interest. The …

FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …

In this study, more than one hundred thousand Escherichia coli and Shigella genomes were
examined and classified. This is, to our knowledge, the largest E. coli genome dataset …

Vibrio cholerae, the etiological agent of cholera, has been a scourge for centuries. Cholera
remains a serious health threat for developing countries and has been responsible for …

Bacteria and Archaea display a variety of phenotypic traits and can adapt to diverse
ecological niches. However, systematic annotation of prokaryotic phenotypes is lacking. We …

Traditional natural product discovery methods have nearly exhausted the accessible
diversity of microbial chemicals, making new sources and techniques paramount in the …

The naming of prokaryotes is governed by the International Code of Nomenclature of
Prokaryotes (ICNP) and partially by the International Code of Nomenclature for Algae, Fungi …